cardiovascular events

The Blood Pressure Drugs that are Linked to Lower Mortality
The Blood Pressure Drugs that are Linked to Lower MortalityA study from the Intermountain Medical Center Heart Institute has shocking findings about certain blood pressure medications and mortality outcomes.
Promising new treatments for plaque psoriasisThe American College of Rheumatology annual meeting wrapped this month in San Diego. Results from long-awaited safety trials show promising new treatments.
FDA: Febuxostat Linked with Increased Risk of Cardiac Death
FDA: Febuxostat Linked with Increased Risk of Cardiac DeathCompared to allopurinol, febuxostat has an increased risk of heart-related deaths.
Why dialing back diabetes treatment is a good ideaA new study has unbelievable findings about treating Medicare patients with diabetes.
New drug approved for heart patientsFDA approved once-daily Yosprala (Aralez), a fixed-dose combination of aspirin, an anti-platelet agent and omeprazole, a proton pump inhibitor (PPI), for patients who require aspirin for secondary prevention of cardiovascular (CV) and cerebrovascular events and who are at risk of developing aspirin-associated gastric ulcers.Here are the top 5 facts to know about Yosprala.
Overtreating glucose levels can take a toll on diabetes patientsMayo Clinic researchers found that beyond overtesting, focus on HbA1C levels can lead to serious harms for patients, especially as more diabetes drugs are needed to keep HbA1C within desired targets.
5 things to know about cholesterol-lowering PCSK9 inhibitorsThis summer, the first two drugs in the new class of cholesterol-lowering medications, known as PCSK9 inhibitors, are expected to be approved by the FDA. If approved, PCSK9 inhibitors will change how chronic conditions are treated.
Statins cost-effective in elderly patients: StudyStatins could be a cost-effective tool for preventing heart attacks and other cardiovascular incidents in adults over aged 75 years, but the benefits would need to be weighed against potential side effects, a study in the Annals of Internal Medicine.
Paracetamol: Is it as safe as we thought?Paracetamol (acetaminophen) is still safer than nonsteroidal anti-inflammatory drugs (NSAIDs), but there is concern about its potential for some side effects not usually considered related to paracetamol, according to a study published in the Annals of Rheumatic Diseases.
Post-MI NSAID/anticoag combo may increase risk of CV bleeding eventsAmong patients receiving antithrombotic therapy (to prevent the formation of blood clots) after a heart attack, the use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with an increased risk of bleeding and events such as heart attack, stroke or cardiovascular death, even after short-term treatment, according to a study in the February 24 issue of JAMA.